The application of vitamin E, the caspase inhibitor Z-VAD-FMK or wedelolactone reduced the serum levels of proinflammatory factors and reversed the contribution of GPX4 deficiency to lethal sepsis in vivo [95]. The gene discussed is GPX4; the disease is Sepsis.